Clinical Trial Update: Citrate-based Regional Anticoagulation Versus Heparin for Continuous Renal Replacement Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing citrate-based regional anticoagulation to heparin for continuous renal replacement therapy in acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Citrate-based regional anticoagulation
• Heparin (unfractionated heparin)

Snippet

Sponsor: University Hospital, Geneva | Conditions: Acute Kidney Injury | Phase 4 | Status: COMPLETED